ATE419536T1 - Biospezifische kontrastmittel - Google Patents

Biospezifische kontrastmittel

Info

Publication number
ATE419536T1
ATE419536T1 AT03711417T AT03711417T ATE419536T1 AT E419536 T1 ATE419536 T1 AT E419536T1 AT 03711417 T AT03711417 T AT 03711417T AT 03711417 T AT03711417 T AT 03711417T AT E419536 T1 ATE419536 T1 AT E419536T1
Authority
AT
Austria
Prior art keywords
sample
condition
quantum dots
metallic nanoparticles
contrast agents
Prior art date
Application number
AT03711417T
Other languages
English (en)
Inventor
Konstantin Sokolov
Brian Korgel
Andrew Ellington
Rebecca Richards-Kortum
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE419536T1 publication Critical patent/ATE419536T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
AT03711417T 2002-03-05 2003-03-05 Biospezifische kontrastmittel ATE419536T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36192402P 2002-03-05 2002-03-05

Publications (1)

Publication Number Publication Date
ATE419536T1 true ATE419536T1 (de) 2009-01-15

Family

ID=27805093

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03711417T ATE419536T1 (de) 2002-03-05 2003-03-05 Biospezifische kontrastmittel

Country Status (7)

Country Link
US (2) US20040023415A1 (de)
EP (1) EP1487343B1 (de)
AT (1) ATE419536T1 (de)
AU (1) AU2003213729A1 (de)
CA (1) CA2478083A1 (de)
DE (1) DE60325564D1 (de)
WO (1) WO2003075765A1 (de)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8614169B2 (en) * 2001-12-04 2013-12-24 Wayne State University Neoepitope detection of disease using protein arrays
US7964536B2 (en) * 2001-12-04 2011-06-21 Wayne State University Neoepitope detection of disease using protein arrays
US20040023415A1 (en) * 2002-03-05 2004-02-05 Konstantin Sokolov Biospecific contrast agents
JP2006508095A (ja) 2002-05-07 2006-03-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 粒子の生物活性化
US8020433B2 (en) * 2003-03-25 2011-09-20 Tearlab Research, Inc. Systems and methods for a sample fluid collection device
US7810380B2 (en) * 2003-03-25 2010-10-12 Tearlab Research, Inc. Systems and methods for collecting tear film and measuring tear film osmolarity
US6965434B2 (en) * 2002-09-13 2005-11-15 Centre National De La Recherche Scientifiques (C.N.R.S.) Method and device for photothermal imaging tiny metal particles immersed in a given medium
US7623908B2 (en) * 2003-01-24 2009-11-24 The Board Of Trustees Of The University Of Illinois Nonlinear interferometric vibrational imaging
JP4787938B2 (ja) * 2003-03-28 2011-10-05 ザ・プロウボウスト・フェロウズ・ファウンデーション・スカラーズ・アンド・ザ・アザー・メンバーズ・オブ・ボード・オブ・ザ・カレッジ・オブ・ザ・ホリー・アンド・アンデバイデッド・トリニティ・オブ・クイーン 銀ナノ粒子を用いた検体検出用センサ
US20050250094A1 (en) * 2003-05-30 2005-11-10 Nanosphere, Inc. Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes
US20050176029A1 (en) * 2003-10-20 2005-08-11 The Regents Of The University Of California Nanoscale transduction systems for detecting molecular interactions
AU2003285133A1 (en) * 2003-11-05 2005-06-24 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Biofunctionalized quantum dots for biological imaging
US7610074B2 (en) * 2004-01-08 2009-10-27 The Board Of Trustees Of The University Of Illinois Multi-functional plasmon-resonant contrast agents for optical coherence tomography
DE102004013052A1 (de) * 2004-03-10 2005-09-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Charakterisierung von technischen Oberflächen
US20050220714A1 (en) * 2004-04-01 2005-10-06 Susan Kauzlarich Agents for use in magnetic resonance and optical imaging
US8128908B2 (en) * 2004-04-30 2012-03-06 University Of Florida Research Foundation, Inc. Nanoparticles and their use for multifunctional bioimaging
US7943396B2 (en) 2004-06-22 2011-05-17 The Regents Of The University Of California Peptide-coated nanoparticles with graded shell compositions
WO2006005065A2 (en) * 2004-06-30 2006-01-12 University Of South Florida Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detection
US20060057627A1 (en) * 2004-09-08 2006-03-16 Board Of Regents, The University Of Texas System Selection scheme for enzymatic function
CA2520670A1 (en) * 2004-09-23 2006-03-23 National Research Council Of Canada Nanocrystal coated surfaces
US20080093550A1 (en) * 2004-11-12 2008-04-24 Seoul National University Industry Foundation Method For Adhering Nanostructures to End of Probe of Microscope and Microscope Having Probe Made By the Same Method
US8346346B1 (en) 2005-01-24 2013-01-01 The Board Of Trustees Of The Leland Stanford Junior University Optical analysis system and approach therefor
US7307774B1 (en) 2005-01-24 2007-12-11 The Board Of Trustees Of The Leland Standford Junior University Micro-optical analysis system and approach therefor
US8788021B1 (en) 2005-01-24 2014-07-22 The Board Of Trustees Of The Leland Stanford Junior Univerity Live being optical analysis system and approach
US7586618B2 (en) 2005-02-28 2009-09-08 The Board Of Trustees Of The University Of Illinois Distinguishing non-resonant four-wave-mixing noise in coherent stokes and anti-stokes Raman scattering
US7725169B2 (en) * 2005-04-15 2010-05-25 The Board Of Trustees Of The University Of Illinois Contrast enhanced spectroscopic optical coherence tomography
US8355776B2 (en) 2005-05-27 2013-01-15 Board Of Regents, The University Of Texas System Hemoglobin contrast in magneto-motive optical doppler tomography, optical coherence tomography, and ultrasound imaging methods and apparatus
US8454511B2 (en) 2005-05-27 2013-06-04 Board Of Regents, The University Of Texas System Magneto-motive ultrasound detection of magnetic nanoparticles
US7801590B2 (en) * 2005-05-27 2010-09-21 Board Of Regents, The University Of Texas System Optical coherence tomographic detection of cells and killing of the same
CA2609965A1 (en) * 2005-05-27 2006-11-30 Board Of Regents, The University Of Texas System Optical coherence tomographic detection of cells and compositions
US20080206152A1 (en) 2005-06-07 2008-08-28 Koninklijke Philips Electronics, N.V. In Vivo Expression Profiling
WO2007006039A2 (en) * 2005-07-05 2007-01-11 The Board Of Regents Of The University Of Texas System Depth-resolved spectroscopy method and apparatus
JP2007023058A (ja) * 2005-07-12 2007-02-01 Fujifilm Holdings Corp 金属酸化物又は金属硫化物ナノ粒子蛍光体を用いる癌検出方法
US7787129B2 (en) 2006-01-31 2010-08-31 The Board Of Trustees Of The University Of Illinois Method and apparatus for measurement of optical properties in tissue
US7951776B2 (en) 2006-09-01 2011-05-31 American Type Culture Collection Methods for treatment of type 1 diabetes
EP2060916A4 (de) * 2006-09-14 2010-09-22 Konica Minolta Med & Graphic Fluoreszenz-halbleitermikropartikelanordnung, fluoreszenzmarkierungsmittelanordnung für eine biologische substanz und biologisches bildgebungsverfahren sowie analyseverfahren für biologische substanzen mit verwendung der anordnungen
US8026108B1 (en) * 2006-10-19 2011-09-27 The University Of Central Florida Research Foundation, Inc. Detection of biotargets using bioreceptor functionalized nanoparticles
US7654716B1 (en) 2006-11-10 2010-02-02 Doheny Eye Institute Enhanced visualization illumination system
EP2092297A4 (de) 2006-11-21 2018-01-17 California Institute of Technology Nanoröhrchen für harmonische zweitbildgebung und verfahren zu ihrer verwendung
US8426152B2 (en) * 2007-01-03 2013-04-23 Lamdagen Corporation Enzymatic assay for LSPR
GB0701444D0 (en) * 2007-01-25 2007-03-07 Iti Scotland Ltd Detecting analytes
WO2008101019A2 (en) * 2007-02-13 2008-08-21 Board Of Regents, The University Of Texas System Molecular specific photoacoustic imaging
EP2129964A4 (de) * 2007-02-28 2013-11-06 Doheny Eye Inst Tragbares beleuchtungssystem
CN101679022A (zh) * 2007-04-02 2010-03-24 爱默蕾大学 使用表面增强拉曼纳米粒子标记物的体内肿瘤靶向和光谱检测
AU2008296733B2 (en) 2007-08-08 2013-07-11 The Board Of Regents Of The University Of Texas System VEGFR-1/NRP-1 targeting peptides
US20110052572A1 (en) * 2007-08-15 2011-03-03 Yeda Research And Development Co. Ltd Regulators of mmp-9 and uses therof
US8238942B2 (en) * 2007-11-21 2012-08-07 Trapeze Networks, Inc. Wireless station location detection
US8983580B2 (en) 2008-01-18 2015-03-17 The Board Of Trustees Of The University Of Illinois Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors
US8115934B2 (en) 2008-01-18 2012-02-14 The Board Of Trustees Of The University Of Illinois Device and method for imaging the ear using optical coherence tomography
US7751057B2 (en) 2008-01-18 2010-07-06 The Board Of Trustees Of The University Of Illinois Magnetomotive optical coherence tomography
US8488863B2 (en) * 2008-11-06 2013-07-16 Los Alamos National Security, Llc Combinational pixel-by-pixel and object-level classifying, segmenting, and agglomerating in performing quantitative image analysis that distinguishes between healthy non-cancerous and cancerous cell nuclei and delineates nuclear, cytoplasm, and stromal material objects from stained biological tissue materials
WO2010090844A2 (en) * 2009-01-21 2010-08-12 California Institute Of Technology Multipurpose analysis using second harmonic generating nanoprobes
WO2010099543A2 (en) * 2009-02-27 2010-09-02 Inter-Med, Inc. Compositions and methods for detecting oral neoplasm
WO2011041701A2 (en) * 2009-10-02 2011-04-07 The Brigham And Women's Hospital, Inc. Inplantable contrast agents and methods
EP3372206A1 (de) 2010-05-13 2018-09-12 Doheny Eye Institute Autonome beleuchtete infusionskanülensysteme und vorrichtungen
US9448173B2 (en) 2011-03-08 2016-09-20 The Board Of Trustees Of The University Of Illinois Dye-conjugated dendrimers
EP2715354A4 (de) 2011-05-27 2015-04-29 Univ Drexel Klare randbestimmung während einer krebschirurgie
US9155497B1 (en) 2011-06-02 2015-10-13 Stc.Unm Compact biosensor of matrix metalloproteinase with cadmium free quantum dots
US20140302491A1 (en) * 2011-10-28 2014-10-09 The Board Of Trustees Of The Leland Stanford Junior University Ex Vivo Culture, Proliferation and Expansion of Primary Tissue Organoids
WO2013078410A1 (en) 2011-11-21 2013-05-30 California Institute Of Technology Functionalization of and use of functionalized second harmonic generating nanoprobes
US8984733B2 (en) 2013-02-05 2015-03-24 Artventive Medical Group, Inc. Bodily lumen occlusion
JP6568802B2 (ja) * 2013-02-20 2019-08-28 コーネル ユニバーシティＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ 多層蛍光性ナノ粒子及びその製造並びに使用方法
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US10149968B2 (en) * 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9092691B1 (en) * 2014-07-18 2015-07-28 Median Technologies System for computing quantitative biomarkers of texture features in tomographic images
CA2959073A1 (en) 2014-09-23 2016-03-31 Tearlab Research, Inc. Systems and methods for integration of microfluidic tear collection and lateral flow analysis of analytes of interest
US10830639B2 (en) 2014-09-25 2020-11-10 Northwestern University Devices, methods, and systems relating to super resolution imaging
US10588564B2 (en) * 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
WO2016105769A1 (en) * 2014-12-23 2016-06-30 Boston Scientific Scimed, Inc. Marker for detection and confirmation of peripheral lung nodules
TWI608076B (zh) * 2015-03-04 2017-12-11 納諾柯技術有限公司 以金屬硫醇聚合物穩定化的量子點
US10845312B2 (en) 2015-07-22 2020-11-24 The Board Of Regents Of The University Of Texas System Label-free detection of sialic acid using surface-enhanced Raman scattering microscopy
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
US11180735B2 (en) 2016-10-28 2021-11-23 The Board Of Trustees Of The Leland Stanford Junior University Methods to preserve tumor-stromal interactions in culture and therapeutic predictive applications thereof
US10634890B1 (en) 2018-10-26 2020-04-28 General Electric Company Miniaturized microscope for phase contrast and multicolor fluorescence imaging
CA3127027A1 (en) * 2019-01-17 2020-07-23 University Health Network Tissue phantoms
AU2020395181A1 (en) * 2019-12-05 2022-06-30 Imaginab, Inc. Methods of imaging using multiple imaging agents
WO2023137542A1 (en) * 2022-01-19 2023-07-27 University Of Ottawa Compositions with metal nanoparticles, their methods of manufacture and their uses

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8331514D0 (en) * 1983-11-25 1984-01-04 Janssen Pharmaceutica Nv Visualization method
US4752569A (en) * 1984-06-21 1988-06-21 The Regents Of The University Of California Sialylated Lewisx epitope, antibodies and diagnosis
GB8426467D0 (en) 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
WO1990006718A1 (en) * 1988-12-21 1990-06-28 Massachusetts Institute Of Technology A method for laser induced fluorescence of tissue
EP0739904A1 (de) 1989-06-29 1996-10-30 Medarex, Inc. Bispezifische Reagenzien für die AIDS-Therapie
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
KR970002255B1 (ko) 1990-06-11 1997-02-26 넥스스타 파아마슈티컬드, 인크. 핵산 리간드
WO1992005285A1 (en) 1990-09-21 1992-04-02 Fred Hutchinson Cancer Research Center Protein sequence-specific oligonucleotide sequences
CA2104698A1 (en) 1991-02-21 1992-08-22 John J. Toole Aptamers specific for biomolecules and methods of making
US5840867A (en) 1991-02-21 1998-11-24 Gilead Sciences, Inc. Aptamer analogs specific for biomolecules
EP0586505A1 (de) 1991-05-14 1994-03-16 Repligen Corporation Heterokonjugat-antikörper zur behandlung von hiv-infektionen
US5582981A (en) 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5217594A (en) * 1992-01-15 1993-06-08 Enzyme Technology Research Group, Inc. Convenient determination of trace lead in whole blood and other fluids
US5756291A (en) * 1992-08-21 1998-05-26 Gilead Sciences, Inc. Aptamers specific for biomolecules and methods of making
US5421339A (en) * 1993-05-12 1995-06-06 Board Of Regents, The University Of Texas System Diagnosis of dysplasia using laser induced fluoroescence
US6159445A (en) * 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
US5681702A (en) 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US5631146A (en) * 1995-01-19 1997-05-20 The General Hospital Corporation DNA aptamers and catalysts that bind adenosine or adenosine-5'-phosphates and methods for isolation thereof
US5991653A (en) * 1995-03-14 1999-11-23 Board Of Regents, The University Of Texas System Near-infrared raman spectroscopy for in vitro and in vivo detection of cervical precancers
US6258576B1 (en) 1996-06-19 2001-07-10 Board Of Regents, The University Of Texas System Diagnostic method and apparatus for cervical squamous intraepithelial lesions in vitro and in vivo using fluorescence spectroscopy
US5697373A (en) * 1995-03-14 1997-12-16 Board Of Regents, The University Of Texas System Optical method and apparatus for the diagnosis of cervical precancers using raman and fluorescence spectroscopies
US5699795A (en) 1995-03-31 1997-12-23 Board Of Regents, The University Of Texas System Optical probe for the detection of cervical neoplasia using fluorescence spectroscopy and apparatus incorporating same
US5612540A (en) * 1995-03-31 1997-03-18 Board Of Regents, The University Of Texas Systems Optical method for the detection of cervical neoplasias using fluorescence spectroscopy
US6111095A (en) 1995-06-07 2000-08-29 Merck & Co., Inc. Capped synthetic RNA, analogs, and aptamers
DE19543750C2 (de) * 1995-11-24 1997-10-23 Crinos Industria Farmaco Cathepsin G inhibierende Aptamere
EP0882224A4 (de) * 1996-02-22 1999-06-09 Dexall Biochemical Labs Inc Flüssigphaseimmunoassay mit nicht eingefangenem substrat
US5750411A (en) * 1996-06-03 1998-05-12 Bayer Corporation Sol particle decay protection immunoassay
US5792613A (en) * 1996-06-12 1998-08-11 The Curators Of The University Of Missouri Method for obtaining RNA aptamers based on shape selection
US5842995A (en) 1996-06-28 1998-12-01 Board Of Regents, The Univerisity Of Texas System Spectroscopic probe for in vivo measurement of raman signals
US6135965A (en) 1996-12-02 2000-10-24 Board Of Regents, The University Of Texas System Spectroscopic detection of cervical pre-cancer using radial basis function networks
US5939021A (en) * 1997-01-23 1999-08-17 Hansen; W. Peter Homogeneous binding assay
US5929985A (en) * 1997-03-18 1999-07-27 Sandia Corporation Multispectral imaging probe
US5920399A (en) * 1997-03-18 1999-07-06 Sandia Corporation Multispectral imaging method and apparatus
US6275726B1 (en) * 1997-05-15 2001-08-14 Board Of Regents, The University Of Texas System Methods of enhanced light transmission through turbid biological media
EP1071473B1 (de) * 1997-10-20 2007-10-10 Board Of Regents, The University Of Texas System Essigsäure als signalverbesserendes kontrastmittel in der fluoreszenzspektroscopie
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6699724B1 (en) * 1998-03-11 2004-03-02 Wm. Marsh Rice University Metal nanoshells for biosensing applications
DE59913716D1 (de) * 1998-10-29 2006-09-07 Dakocytomation Denmark As Nachweis von säure-resistenten mikroorganismen im stuhl
US6251616B1 (en) * 1999-01-14 2001-06-26 Biocrystal Ltd. Methods and assay kits for detecting altered mononuclear cell phenotype related to a pro-tumor immune response
US6465180B1 (en) * 1999-03-17 2002-10-15 The Regents Of The University Of California Detection of premalignant melanocytes
US20010055764A1 (en) * 1999-05-07 2001-12-27 Empedocles Stephen A. Microarray methods utilizing semiconductor nanocrystals
US6680377B1 (en) * 1999-05-14 2004-01-20 Brandeis University Nucleic acid-based detection
EP1226153B1 (de) * 1999-10-26 2010-03-03 University of Utah Research Foundation Fluoreszierende cobalamine und deren verwendung
US20040023415A1 (en) * 2002-03-05 2004-02-05 Konstantin Sokolov Biospecific contrast agents

Also Published As

Publication number Publication date
CA2478083A1 (en) 2003-09-18
WO2003075765A1 (en) 2003-09-18
DE60325564D1 (de) 2009-02-12
US20090068108A1 (en) 2009-03-12
US20040023415A1 (en) 2004-02-05
AU2003213729A1 (en) 2003-09-22
EP1487343A1 (de) 2004-12-22
EP1487343B1 (de) 2008-12-31
EP1487343A4 (de) 2007-03-21

Similar Documents

Publication Publication Date Title
ATE419536T1 (de) Biospezifische kontrastmittel
Jayanthi et al. Recent advances in biosensor development for the detection of cancer biomarkers
Fedele Diagnostic aids in the screening of oral cancer
WO2005020803A3 (en) Raman imaging and sensing apparatus employing nanoantennas
Rahman et al. Evaluation of a low-cost, portable imaging system for early detection of oral cancer
SG144722A1 (en) Method and apparatus for detecting and imaging the presence of biological materials
Huang et al. Gold nanoparticle based platforms for circulating cancer marker detection
Lutz et al. Raman nanoparticle probes for antibody-based protein detection in tissues
Wu et al. How nanoparticles transform single molecule measurements into quantitative sensors
WO2007056523A3 (en) Methods for diagnosing and monitoring the progression of cancer
Poh et al. Squamous cell carcinoma and precursor lesions: diagnosis and screening in a technical era
EP1917528A4 (de) Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
WO2007109881A8 (en) Biomarkers useful for diagnosing prostate cancer, and methods thereof
EP1498722A3 (de) Ramansonde und ihre Anwendung in einer Vorrichtung zur Messung von Ramanspektren
CN113167791A (zh) 作为通用增强剂的超亮荧光纳米构建体
WO2006014576A3 (en) Fluorescent lifetime biological detection and imaging using water-stable semiconductor nanocrystals
Baeten et al. Molecular imaging of oral premalignant and malignant lesions using fluorescently labeled lectins
Mahfoud et al. Detection of ErbB2: nanotechnological solutions for clinical diagnostics
Tukimin et al. Polarized light-based cancer cell detection techniques: a review
Chakraborty et al. Nano‐diagnostics as an emerging platform for oral cancer detection: Current and emerging trends
Liu et al. Development of microfluidic platform capable of high-throughput absolute quantification of single-cell multiple intracellular proteins from tumor cell lines and patient tumor samples
KR20110039170A (ko) 나노 스페이서를 이용한 광학 센서 및 광학 센서를 이용한 검출 방법
WO2006007064A3 (en) System and method for spectroscopy and imaging
Seekell et al. Feasibility study of brain tumor delineation using immunolabeled gold nanorods
WO2004096971A3 (de) Verfahren zur schnellen bestimmung von qualitäten/qualitätsänderungen beliebiger systeme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties